Torasemide versus furosemide in patients with congestive heart failure: A double-masked, randomized study

Current Therapeutic Research - Clinical and Experimental

Volumn 58, Issue 5, 1997, Pages 291-299

  Ferrara, Nicola ^a,b,c   Leosco, Dario ^a   Del Prete, Mario ^a   Lombardi, Luigi ^a   Landino, Pietro ^a   Abete, Pasquale ^a   Longobardi, Giancarlo ^b   Rengo, Franco ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Division of Cardiology   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Diuretics; Heart failure; Renal tube; Torasemide

Indexed keywords

FUROSEMIDE; LOOP DIURETIC AGENT; POTASSIUM; SODIUM; TORASEMIDE;

ADULT; AGED; ARTICLE; CALCIURESIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIURESIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MUSCLE CRAMP; NATRIURESIS; POTASSIUM BLOOD LEVEL; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL;

EID: 0030918649     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(97)80026-4     Document Type: Article

References (12)

1. Lesne M, Clerckx-Braun F, Duhoux F, et al. Pharmacokinetics of a new diuretic, torasemide in man. Arch Int Pharmacodyn Ther. 1981;249:322-325.
2. Lesne M, Clerckx-Braun F, Duhoux F, et al. Pharmacokinetic study of torasemide in humans: An overview of its diuretic effect. Int J Clin Pharmacol Ther Toxicol. 1982;20: 382-387.
3. Dunn CJ, Fitton A, Brogden RN. Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drug. 1995;49:121-142.
4. Brater DC, Leinfelder J, Anderson SA. Clinical pharmacology of torasemide, a new loop diuretic. Clin Pharmacol Ther. 1987;42:187-192.
5. Puschett JB, Jordan LL. Mode of action of torasemide in man. In: Kruck F, Mutschler E, Knauf H eds. Torasemide: Clinical Pharmacology and Therapeutic Applications. Stuttgart: Gustav Fischer Verlag; 1990:3-13.
6. Schmider RE, Rockstroh JK. Efficacy and tolerance of low-dose loop diuretic in hypertension. Cardiology. 1994;84(Suppl 2P):36-42.
7. Russo D, Minutolo R, Andreucci VE. Role of loop diuretics in chronic renal failure. Cardiology. 1994;84(Suppl 2P):162-170.
8. Podszus T, Wagner U, Ploch T. Clinical and haemodynamic effects of long-term treatment with torasemide in congestive heart failure. Cardiology. 1994;84(Suppl 2P):124-130.
9. Broekhuysen J, Deger F, Douchamps J, et al. Torasemide, a new potent diuretic: Double blind comparison with furosemide. Eur J Clin Pharmacol. 1986;31(Suppl):29-34.
10. Greger R, Schlatter E. Cellular mechanism of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin Wochenschr. 1983;61:1019-1027.
11. Knox FG, Wright FS, Howards SS, Berliner RW. Effect of furosemide on sodium reabsorption by proximal tubule of the dog. Am J Physiol. 1969;217:192-198.
12. Langbehn AF, Achhammer I, Bolke T. Acute hemodynamic effects of 20 mg torasemide and 20 mg furosemide given intravenously to patients with congestive heart failure. In: Kruck F, Mutschler E, Knauf H, eds. Torasemide: Clinical Pharmacology and Therapeutic Applications. Stuttgart: Gustav Fischer Verlag; 1990:147-155.